サマリー

The global cell isolation market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 17% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Cell isolation, or separation, refers to the process of identifying and removing one or more specific cells from a heterogeneous mixture of cell population. The targeted cells are identified, isolated and separated according to their type. Some commonly used methods for cell isolation include magnet-activated cell separation, filtration, centrifugation and flow cytometry. Cell isolation is also used to diagnose diseases, cellular research and therapies by analyzing the ribonucleic acid (RNA) expressions. It aids in minimizing experimental complexity while analyzing the cells and reducing the interference from other cell types within the sample. As a result, it finds extensive application in cancer research, stem cell biology, immunology and neurology.

Cell Isolation Market Trends:
Significant growth in the medical and pharmaceutical industries is one of the key factors creating a positive outlook for the market. Furthermore, increasing emphasis on cell-based research is providing a thrust to the market growth. Researchers actively utilize isolated cells to develop novel cell therapies and cell-based treatments for various chronic medical ailments. Pharmaceutical manufacturers are also widely using cell isolation technologies to improve drug discovery and develop drugs with enhanced efficacies. In line with this, the increasing requirement for personalized medicines is also contributing to the growth of the market. Additionally, the development of advanced separation tools for proteins, nucleic acids, chromatin and other complex cells for subsequent analysis is also contributing to the growth of the market. Other factors, including extensive research and development (R&D) activities in the field of biotechnology, along with the implementation of favorable government policies, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cell isolation market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technique, cell type, product, application and end use.

Breakup by Technique:

Centrifugation
Surface Marker
Filtration

Breakup by Cell Type:

Human Cells
Animal Cells

Breakup by Product:

Consumables
Reagents, Kits, Media and Sera
Beads
Disposables
Instruments
Centrifuges
Flow Cytometers
Filtration Systems
Magnetic-activated Cell Separator Systems

Breakup by Application:

Biomolecule Isolation
Therapeutics
Stem Cell Research
Cancer Research
Tissue Regeneration
In-Vitro Diagnostics

Breakup by End Use:

Biotechnology and Biopharmaceutical Companies
Hospitals and Diagnostic Laboratories
Research Laboratories and Institutes
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alfa Laval AB, Becton Dickinson and Company, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., General Electric Company, Merck KGaA, Miltenyi Biotec B.V. & Co. KG, pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG, Roche Holding AG, STEMCELL Technologies Inc., Terumo Corporation and Thermo Fisher Scientific Inc. Key Questions Answered in This Report:
How has the global cell isolation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global cell isolation market?
What are the key regional markets?
What is the breakup of the market based on the technique?
What is the breakup of the market based on the cell type?
What is the breakup of the market based on the product?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end use?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global cell isolation market and who are the key players?
What is the degree of competition in the industry?

ページTOPに戻る

目次

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cell Isolation Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technique
6.1 Centrifugation
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Surface Marker
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Filtration
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Cell Type
7.1 Human Cells
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Animal Cells
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Product
8.1 Consumables
8.1.1 Market Trends
8.1.2 Key Segments
8.1.2.1 Reagents, Kits, Media and Sera
8.1.2.2 Beads
8.1.2.3 Disposables
8.1.3 Market Forecast
8.2 Instruments
8.2.1 Market Trends
8.2.2 Key Segments
8.2.2.1 Centrifuges
8.2.2.2 Flow Cytometers
8.2.2.3 Filtration Systems
8.2.2.4 Magnetic-activated Cell Separator Systems
8.2.3 Market Forecast
9 Market Breakup by Application
9.1 Biomolecule Isolation
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Therapeutics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Stem Cell Research
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Cancer Research
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Tissue Regeneration
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 In-Vitro Diagnostics
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by End Use
10.1 Biotechnology and Biopharmaceutical Companies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Hospitals and Diagnostic Laboratories
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Research Laboratories and Institutes
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Alfa Laval AB
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Becton Dickinson and Company
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Beckman Coulter Inc. (Danaher Corporation)
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 SWOT Analysis
16.3.4 Bio-Rad Laboratories Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 General Electric Company
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck KGaA
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Miltenyi Biotec B.V. & Co. KG
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 pluriSelect Life Science UG (haftungsbeschränkt) & Co. KG
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Roche Holding AG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 STEMCELL Technologies Inc.
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Terumo Corporation
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 Thermo Fisher Scientific Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis